Real Brokerage (REAX) Insider Notice: 20,000 Shares to Be Sold Via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for Real Brokerage Inc (REAX) reports a proposed sale of 20,000 common shares to be executed through Morgan Stanley Smith Barney on NASDAQ on 09/22/2025 for an aggregate market value of $100,064. The shares were acquired by exercise from the issuer on 09/18/2025 and paid in cash the same day. The filing lists the issuer's outstanding shares as 209,300,000.

The filer previously sold common shares during 2025: 1,219 shares on 09/18/2025 for $6,107.19, 151,596 shares on 08/12/2025 for $635,650.00, and 50,000 shares on 06/23/2025 for $200,264.00, totaling 202,815 shares for $842,021.19 in gross proceeds. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Clear disclosure of proposed sale details: broker, sale date (09/22/2025), number of shares (20,000) and aggregate market value ($100,064)
• Acquisition details provided: shares were exercised on 09/18/2025 and paid in cash the same day
• Prior sales disclosed for 2025 (dates, amounts, gross proceeds), enhancing transparency

Negative

• Multiple recent sales in 2025: 202,815 shares sold year-to-date for total gross proceeds of $842,021.19, which could increase share supply from insider selling
• Relationship to issuer not specified in the provided issuer information table, leaving the filers position or role unclear

Insights

Securities Analyst

TL;DR Routine insider sale notice: 20,000 exercised shares to be sold on NASDAQ; prior 2025 sales disclosed.

The filing documents a standard Rule 144 notice for shares acquired by exercise on 09/18/2025 and slated for sale on 09/22/2025 through Morgan Stanley Smith Barney. The transaction size (20,000 shares, $100,064) is disclosed alongside issuer outstanding shares (209,300,000), allowing investors to gauge dilution and potential share supply. Historical sales in 2025 totaling 202,815 shares and $842,021.19 are also reported. This is a disclosure of intent to sell rather than a new corporate event; it provides transparency but does not itself change the companys operating or financial condition.

Compliance / Risk Analyst

TL;DR Filing appears compliant and complete for a Rule 144 notice; includes broker, acquisition and past-sales details.

The form includes required elements: broker name and address, acquisition date and nature (exercised shares), payment method (cash), approximate sale date, and past sales by the same person in the prior three months. The signer affirms no undisclosed material adverse information. No statements in this filing indicate regulatory issues, undisclosed liabilities, or departures from Rule 144 disclosure requirements based on the provided content. Relationship to issuer was not specified in the provided tables.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	100064.00	209300000	09/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2025	Exercised Shares	Issuer			20000	09/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LAURENCE ROSE 701 Brickell Avenue, 17th Floor Miami FL 33131	Common	09/18/2025	1219	6107.19
LAURENCE ROSE 701 Brickell Avenue, 17th Floor Miami FL 33131	Common	08/12/2025	151596	635650.00
LAURENCE ROSE 701 Brickell Avenue, 17th Floor Miami FL 33131	Common	06/23/2025	50000	200264.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for REAX report?

The filing reports a proposed sale of 20,000 common shares on 09/22/2025 through Morgan Stanley Smith Barney with an aggregate market value of $100,064.

How were the 20,000 shares acquired according to the filing?

The shares were exercised from the issuer on 09/18/2025 and paid for in cash on that date.

What prior sales by the same person are disclosed in this Form 144?

Three prior 2025 sales are listed: 06/23/2025 (50,000 shares, $200,264.00), 08/12/2025 (151,596 shares, $635,650.00), and 09/18/2025 (1,219 shares, $6,107.19).

What is the issuer's outstanding share count listed in the filing?

The filing shows 209,300,000 shares outstanding.

Through which broker will the proposed sale be executed?

The sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services (1 New York Plaza, 8th Floor, New York, NY 10004).